• Managing Travel Risks for Patients With Heart Disease
    2026/11/12

    Ashish Sarraju, MD, and Abhayjit Singh, MD, discuss approaches to assessing travel readiness in patients with cardiovascular disease. They review considerations for patients with cardiac devices and advanced heart conditions, strategies for blood clot prevention and key recommendations for medication management and emergency planning during travel.

    Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

    続きを読む 一部表示
    11 分
  • Twenty Years of Innovation in Robotic Cardiac Surgery
    2026/11/05

    Twenty years after launching one of the nation’s earliest robotic cardiac surgery programs, Marc Gillinov, MD, Marijan Koprivanac, MD, and Gianluca Torregrossa, MD, discuss how robotic techniques have evolved from mitral valve repair to encompass aortic valve surgery, aortic procedures and totally endoscopic coronary bypass surgery. They examine clinical outcomes, emerging innovations in minimally invasive cardiac surgery and the role of advanced robotic platforms and AI-enabled technologies in shaping the future of heart surgery.

    Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

    続きを読む 一部表示
    21 分
  • Advancing Cardiovascular Care Through Genetic Testing
    2026/10/29

    Krishna Aragam, MD, Michael Hill, MD, and Christina Rigelsky, MS, CGC, discuss how cardiovascular genomics is transforming the evaluation and management of inherited conditions like heart disease, cardiomyopathies, arrhythmias and aortopathies. The conversation explores genetic testing, family screening, and emerging opportunities to personalize prevention and treatment based on genomic insights.

    Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

    続きを読む 一部表示
    32 分
  • Talking Tall Rounds® Renal Denervation for Uncontrolled Hypertension
    2026/10/22

    In this excerpt from Tall Rounds®, Luke Laffin, MD, discusses the evolving role of renal denervation for uncontrolled hypertension, including guideline recommendations and the physiologic mechanisms underlying blood pressure reduction. Dr. Laffin reviews pivotal clinical trial data and examines the efficacy and safety evidence supporting the integration of renal denervation into contemporary hypertension management.

    View other Tall Rounds programs. https://2207941.mediaspace.kaltura.com/category/Tall+Rounds/75663251

    Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

    続きを読む 一部表示
    12 分
  • Talking Tall Rounds® Cardiac Sarcoidosis: Systematic Team Approach to Diagnosis & Management
    2026/10/15

    In this excerpt from Tall Rounds®, Cleveland Clinic experts discuss imaging modalities that aid the diagnosis of cardiac sarcoidosis. The conversation explores diagnostic challenges, risk stratification, interpretation pitfalls and the role of serial imaging in assessing treatment response and guiding clinical decision-making.

    View other Tall Rounds programs. https://2207941.mediaspace.kaltura.com/category/Tall+Rounds/75663251

    Meet the presenters:
    Amanda Vest, MBBS https://providers.clevelandclinic.org/provider/amanda-vest/4268489
    Christine Jellis, MD https://providers.clevelandclinic.org/provider/christine-jellis/4271993?
    Bryan Abadie, MD https://providers.clevelandclinic.org/provider/bryan-abadie/4959422?

    Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

    続きを読む 一部表示
    17 分
  • Evolving Strategies in Aortic Arch Repair
    2026/10/08

    Eric Roselli, MD, and Patrick Vargo, MD, discuss how advances in open, hybrid and endovascular techniques are changing the treatment of aortic arch disease. They explore evolving approaches to aneurysms and dissections, innovations in brain protection and the role of specialized aortic centers in improving patient outcomes.

    Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

    続きを読む 一部表示
    24 分
  • Management of Complex Aortic Valve Endocarditis
    2026/10/01

    Milind Desai, MD, and Per Wierup, MD, discuss the evaluation and management of high-risk aortic valve endocarditis, including indications for urgent intervention and timing of surgery. They also review operative approaches to patients with heart failure, uncontrolled infection and embolic risk, highlighting the role of multidisciplinary expertise in complex endocarditis care

    Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

    続きを読む 一部表示
    14 分
  • Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk
    2026/09/24

    Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phospholipids and lipoprotein(a). They discuss the potential mechanisms linking lipoprotein(a) to cardiovascular risk and how ongoing phase 3 research may shape future management of patients with elevated lipoprotein(a).

    Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

    Learn more.

    続きを読む 一部表示
    9 分